share_log

Immuneering Q1 EPS $(0.49) Misses $(0.46) Estimate

Benzinga ·  May 7 17:02

Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.46) by 6.52 percent. This is a 3.92 percent increase over losses of $(0.51) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment